http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I714942-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc06cad2b58bbfcc30e3c96a6eb6c926 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 |
| filingDate | 2017-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7866c826dafdc296af6c1a4b30316fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c58748fef48b83faab13b9d2fec8780b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b90abdd7d894f97dc91e2639591837e |
| publicationDate | 2021-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-I714942-B |
| titleOfInvention | Pharmaceutical composition for preventing or treating inflammation induced by dengue fever and its use |
| abstract | The present invention discloses a pharmaceutical composition for preventing or treating inflammation induced by dengue fever and its use, wherein the pharmaceutical composition includes at least one of the 4-methyl umbelliferone sodium salt, and the anti-CD44 antibody for blocking the CD44 antigen on the vascular endothelial cells of a dengue patient. When the level of serum hyaluronan in the dengue patient is higher than or equal to 70 ng/ml by the enzyme-linked immunosorbent assay (ELISA), it indicates that warning signs will be developed in the whole illness course of the patient. |
| priorityDate | 2017-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.